Bringing together clinical and scientific research teams in dedicated high quality research centres.
WWIEM is committed to research excellence in experimental medicine by making scientific breakthroughs in the mechanisms of disease, which we translate to innovative therapeutics to improve patient outcomes.
We are an international hub of excellence on eye disease, infectious diseases and respiratory disease with a core emphasis on immunology, molecular cell biology and patient-based investigations.Discover more about our world-class research facilities
The Institute has significantly invested in clinical infrastructure to support clinical trials.
This includes a UK Clinical Research Collaboration registered Clinical Trials Unit and a Wellcome Trust - Wolfson Clinical Research Facility. This is based within the Belfast City Hospital campus as part of the Health Sciences Campus and supports a range of clinical specialties to deliver clinical research.
The Institute drives research excellence and impact, delivering innovative solutions to the specific challenges we have identified in healthcare.
The Institute drives research excellence and impact, delivering innovative solutions to the specific challenges we have identified in healthcare. The Institute has the following aims:
- Address key global challenges in health care by making scientific breakthroughs in mechanisms of disease, translating these to innovative therapeutics and preventive interventions to improve patient outcomes.
- Establish lasting relationships with major funders for programmatic research and capacity building. This will include doctoral training, clinical academic programmes and postdoctoral fellowships.
- Leverage scientific strengths with small and medium size enterprises and large pharmaceutical companies to develop externally funded competitive, collaborative programmes for discovery and translation.
The Institute is recognised for high quality biomedical and translational research and its impact on patient care in Northern Ireland, nationally and internationally, is the foremost strategic priority of the University.
Supported by national and international partners, the University has already invested over £100m in co-locating researchers in different areas of established excellence alongside the education centres for medicine, biomedical science and dentistry on the Health Sciences Campus and Royal Hospital Campus.
The Institute for Health Sciences synergises basic science, translational technologies, clinical and population sciences research, providing a critical mass of clinical and scientific investigators working in a cross-school, multidisciplinary manner.
These themes have been chosen because they represent global and nationally-relevant health challenges and reflect our international reputation and existing research strengths.
Together the centres will exploit our state of the art infrastructure to promote enhanced interdisciplinary collaboration and drive competitive programmatic research.